08/01/2025
Hershey Update!
For those of you who have already seen the post on my personal page, some of this update will be repeated but I do have some new information, too…
Our trip to Hershey Medical Center last week was productive and we met with Dr. Sholler, the Chief Pediatric Oncologist, and the research team. As a Penn State alum, I was in awe as the entire place is dedicated to PSU, lol! In fact, the actual name of the facility is Penn State Health Milton S. Hershey Medical Center. There are paw prints on the floor, Nittany Lion statues all around, pictures of Dance Marathon (PSU’s philanthropy for the Four Diamonds Fund), and Penn State Starbucks mugs, to name a few!
Anyway, we found out that Penn State is the lead in a consortium that studies the genomics of tumors and then provides recommended treatment plans based on the tumor’s DNA/make up. So, Penny consented to this study and will have a biopsy in Hershey tomorrow. This biopsy will be compared to her initial biopsy in 2020 to determine any changes and to develop the pathway to treat her tumor. The team will duscuss her case in a tumor board meeting and then devise a recommended treatment plan It’ll take @3-4 weeks after her biopsy to finish the research, next discuss in a tumor board meeting, and then we will have a virtual call with the team to discuss the recommendations. So, hopefully we will hear something by mid to latter September.
In the meantime, Penny will start their clinical trial on Monday, August 4th. Her most recent PET showed increased pericardial effusion (in addition to a new tumor and increasing opacities) so Penny had a repeat echocardiogram in Hershey today to make sure the effusion has not increased. Thankfully, it’s about the same so no additional action needs to be taken at this time. She’ll have a repeat echo on August 11th.
Regarding the trial, it involves 21 day cycles and four chemo drugs, two IV chemo drugs and two pills. One of the pills, Silmitasertib, is the research drug. This pill is taken twice a day for every day of the cycle. The other three drugs (Vincristine, Irinotecan, and Temozolomide) are only given on Days 1-5 of each cycle. Unfortunately, that means Penny has to be in Hershey the first week of every cycle. She also has to be there every Monday at least for the first cycle. After the first cycle, she can have bloodwork with her local oncologist.
Side effects can really be anything. They gave us a 23 page packet, lol, and potential side effects were listed for each drug. It’s all the same stuff you’d expect with chemo - nausea, vomiting, diarrhea, fatigue, hair loss, low white blood cell count, immunocompromised, etc. We can only hope that Penny’s effects are mild but we’ll have to wait and see how her body reacts.
Regarding timelime, there really is no end date at this time. Penny will continue the trial as long as she is responding and her body can tolerate the drugs, for up to two years. If the genomics study shows that a different drug will help Penny, they will switch. However, the study could show that her current or past regimen of chemo would be most effective in her case. So time will tell!
While in Hershey, Penny and Matt are able to stay at the Ronald McDonald House which is across the street from the medical center. They have their own room and dinner is provided as well as snacks/drinks available in their kitchen. They’ll be staying there for five nights during the first week of each cycle and then every Sunday night when a Monday visit is required.
Penny is nervous about the trial but also hopeful since we finally have a plan and promising protocols ahead of us. Kaylee already misses her big sister but she will be caught up in a bunch of her own routine medical appts over the next few weeks and then school starts again in four weeks!
I’ll provide another update after Penny’s first week of chemo.